Production (Stage)
The Beauty Health Company
SKIN
$1.61
-$0.12-6.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -17.97% | -16.00% | -12.94% | -6.26% | 4.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.97% | -16.00% | -12.94% | -6.26% | 4.35% |
| Cost of Revenue | -42.58% | -37.42% | -23.01% | 73.09% | 95.40% |
| Gross Profit | 22.19% | 17.52% | -0.16% | -50.99% | -40.73% |
| SG&A Expenses | -10.60% | -11.65% | -12.72% | -9.03% | -1.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.43% | -23.98% | -17.05% | 18.19% | 29.03% |
| Operating Income | 51.91% | 48.23% | 31.33% | -274.60% | -348.21% |
| Income Before Tax | 52.82% | 71.00% | 69.50% | -351.09% | -526.83% |
| Income Tax Expenses | -10.65% | 74.51% | 149.15% | 141.31% | 123.83% |
| Earnings from Continuing Operations | 52.18% | 70.94% | 66.53% | -701.47% | -975.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 52.18% | 70.94% | 66.53% | -701.47% | -975.25% |
| EBIT | 51.91% | 48.23% | 31.33% | -274.60% | -348.21% |
| EBITDA | 66.20% | 64.57% | 50.31% | -1,111.59% | -1,720.38% |
| EPS Basic | 49.16% | 69.02% | 64.71% | -681.83% | -846.81% |
| Normalized Basic EPS | 42.57% | 36.91% | 30.66% | -574.35% | -649.22% |
| EPS Diluted | 41.19% | 43.74% | 38.59% | -425.60% | -191.58% |
| Normalized Diluted EPS | 43.40% | 41.77% | 36.29% | -545.53% | -626.48% |
| Average Basic Shares Outstanding | -3.90% | -5.97% | -6.83% | -8.24% | -9.56% |
| Average Diluted Shares Outstanding | -4.33% | 1.54% | 0.55% | -1.21% | -6.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |